ArticleFrontiers in digital health2026
Association between wrist-worn actigraphy and the MDS-UPDRS Parkinson's disease rating scale through machine learning: an exploratory study.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is typically assessed during short clinical visits using rating scales such as the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). These assessments provide only a snapshot of symptom severity and may not capture fluctuations in daily life. In this study, we examined whether wrist-worn actigraphy can be used to estimate MDS-UPDRS scores in people with Parkinson's disease (PwP). Methods: Continuous accelerometer recordings at 25 Hz were collected over up to 28 days using GeneActiv devices. From these recordings, three feature representations were derived: non-embedding actigraphy features, self-supervised accelerometer embeddings, and a combined feature set. A small set of regression models was evaluated using strict leave-one-participant-out cross-validation (LOPO-CV). Results: Estimation performance varied across targets and feature sets. The strongest result was observed for MDS-UPDRS Part IV, where non-embedding features with Elastic Net achieved a mean absolute error (MAE) of 1.6 and a correlation of 0.83 between estimated and actual values. The combined feature set performed best for Part I (MAE = 3.0, Discussion: Overall, the results show that month-long wrist-worn actigraphy contains information related to PD severity in daily life, although estimation accuracy remains limited and depends on the MDS-UPDRS target. Wearable-derived measures may therefore provide complementary information to clinical assessments, particularly for motor complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.